eLife (Mar 2020)
Agonist-mediated switching of ion selectivity in TPC2 differentially promotes lysosomal function
- Susanne Gerndt,
- Cheng-Chang Chen,
- Yu-Kai Chao,
- Yu Yuan,
- Sandra Burgstaller,
- Anna Scotto Rosato,
- Einar Krogsaeter,
- Nicole Urban,
- Katharina Jacob,
- Ong Nam Phuong Nguyen,
- Meghan T Miller,
- Marco Keller,
- Angelika M Vollmar,
- Thomas Gudermann,
- Susanna Zierler,
- Johann Schredelseker,
- Michael Schaefer,
- Martin Biel,
- Roland Malli,
- Christian Wahl-Schott,
- Franz Bracher,
- Sandip Patel,
- Christian Grimm
Affiliations
- Susanne Gerndt
- Department of Pharmacy – Center for Drug Research, Ludwig-Maximilians-Universität, Munich, Germany; Walther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, Ludwig-Maximilians-Universität, Munich, Germany
- Cheng-Chang Chen
- ORCiD
- Department of Pharmacy – Center for Drug Research, Ludwig-Maximilians-Universität, Munich, Germany
- Yu-Kai Chao
- ORCiD
- Walther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, Ludwig-Maximilians-Universität, Munich, Germany
- Yu Yuan
- Department of Cell and Developmental Biology, University College London, London, United Kingdom
- Sandra Burgstaller
- Molecular Biology and Biochemistry, Gottfried Schatz Research Center, Medical University of Graz, Graz, Austria
- Anna Scotto Rosato
- Walther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, Ludwig-Maximilians-Universität, Munich, Germany
- Einar Krogsaeter
- ORCiD
- Walther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, Ludwig-Maximilians-Universität, Munich, Germany
- Nicole Urban
- Rudolf-Boehm-Institute for Pharmacology and Toxicology, Universität Leipzig, Leipzig, Germany
- Katharina Jacob
- Walther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, Ludwig-Maximilians-Universität, Munich, Germany
- Ong Nam Phuong Nguyen
- Department of Pharmacy – Center for Drug Research, Ludwig-Maximilians-Universität, Munich, Germany
- Meghan T Miller
- Department of Pharmacy – Center for Drug Research, Ludwig-Maximilians-Universität, Munich, Germany; Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
- Marco Keller
- Department of Pharmacy – Center for Drug Research, Ludwig-Maximilians-Universität, Munich, Germany
- Angelika M Vollmar
- Department of Pharmacy – Center for Drug Research, Ludwig-Maximilians-Universität, Munich, Germany
- Thomas Gudermann
- Walther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, Ludwig-Maximilians-Universität, Munich, Germany
- Susanna Zierler
- ORCiD
- Walther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, Ludwig-Maximilians-Universität, Munich, Germany
- Johann Schredelseker
- ORCiD
- Department of Pharmacy – Center for Drug Research, Ludwig-Maximilians-Universität, Munich, Germany; Walther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, Ludwig-Maximilians-Universität, Munich, Germany
- Michael Schaefer
- Department of Pharmacy – Center for Drug Research, Ludwig-Maximilians-Universität, Munich, Germany; Rudolf-Boehm-Institute for Pharmacology and Toxicology, Universität Leipzig, Leipzig, Germany
- Martin Biel
- Department of Pharmacy – Center for Drug Research, Ludwig-Maximilians-Universität, Munich, Germany
- Roland Malli
- ORCiD
- Molecular Biology and Biochemistry, Gottfried Schatz Research Center, Medical University of Graz, Graz, Austria
- Christian Wahl-Schott
- Institute for Neurophysiology, Hannover Medical School, Hannover, Germany
- Franz Bracher
- Department of Pharmacy – Center for Drug Research, Ludwig-Maximilians-Universität, Munich, Germany
- Sandip Patel
- Department of Cell and Developmental Biology, University College London, London, United Kingdom
- Christian Grimm
- ORCiD
- Walther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, Ludwig-Maximilians-Universität, Munich, Germany
- DOI
- https://doi.org/10.7554/eLife.54712
- Journal volume & issue
-
Vol. 9
Abstract
Ion selectivity is a defining feature of a given ion channel and is considered immutable. Here we show that ion selectivity of the lysosomal ion channel TPC2, which is hotly debated (Calcraft et al., 2009; Guo et al., 2017; Jha et al., 2014; Ruas et al., 2015; Wang et al., 2012), depends on the activating ligand. A high-throughput screen identified two structurally distinct TPC2 agonists. One of these evoked robust Ca2+-signals and non-selective cation currents, the other weaker Ca2+-signals and Na+-selective currents. These properties were mirrored by the Ca2+-mobilizing messenger, NAADP and the phosphoinositide, PI(3,5)P2, respectively. Agonist action was differentially inhibited by mutation of a single TPC2 residue and coupled to opposing changes in lysosomal pH and exocytosis. Our findings resolve conflicting reports on the permeability and gating properties of TPC2 and they establish a new paradigm whereby a single ion channel mediates distinct, functionally-relevant ionic signatures on demand.
Keywords